Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT1 | Q96EB6 | 3/20 | 1.00 |
| ▸ | HEXA | P06865 | 14/20 | 0.90 |
| ▸ | HEXB | P07686 | 14/20 | 0.90 |
| ▸ | OGA | O60502 | 1/20 | 0.90 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | AHR | P35869 | 1/20 | 0.57 |
| ▸ | RAD52 | P43351 | 1/20 | 0.57 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Elinafide SCHEMBL6256967 | 1.00 | SIRT1 (1.00) | SIRT1HEXAHEXBOGAMEN1 | |
| Elinafide SCHEMBL29441732 | 1.00 | SIRT1 (1.00) | SIRT1HEXAHEXBOGAMEN1 | |
| SCHEMBL8396162 | 0.97 | SIRT1 (0.94) | SIRT1HEXAHEXBOGAMEN1 | |
| SCHEMBL31011151 | 0.95 | HEXA (1.00) | SIRT1HEXAHEXBOGA | |
| SCHEMBL4408773 | 0.95 | HEXA (1.00) | SIRT1HEXAHEXBOGA | |
| Bnipdpta SCHEMBL13909966 | 0.94 | SIRT1 (0.88) | SIRT1HEXAHEXBOGAMEN1 | |
| SCHEMBL13909979 | 0.94 | SIRT1 (0.88) | SIRT1HEXAHEXBOGAMEN1 | |
| SCHEMBL3290712 | 0.93 | SIRT1 (0.86) | SIRT1HEXAHEXBOGA | |
| SCHEMBL14524900 | 0.93 | SIRT1 (0.86) | SIRT1HEXAHEXBOGANR1I2 | |
| Bnipspd SCHEMBL13909975 | 0.92 | SIRT1 (0.91) | SIRT1HEXAHEXBOGAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3065 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083866-A1 | COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-26 | — | — | US | claimed |
| US-20260055182-A1 | ANTI-L1-CAM ANTIBODIES AND THEIR USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | CIS BIOPHARMA AG (CH) | 2026-02-26 | — | — | US | claimed |
| US-20250326856-A1 | HUMANIZED ANTI-CD45 ANTIBODIES AND USES THEREOF | Fred Hutchison Cancer Center (US) | 2025-10-23 | — | — | US | claimed |
| EP-4615580-A1 | ANTI-L1-CAM ANTIBODIES AND THEIR USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | CIS Biopharma AG (CH) | 2025-09-17 | — | — | EP | claimed |
| US-12398402-B2 | Reducing CD33 expression to selectively protect therapeutic cells | FRED HUTCHINSON CANCER CENTER (US) | 2025-08-26 | — | — | US | claimed |
| US-20250249125-A1 | ANTI-CD90 ANTIBODIES, BINDING FRAGMENTS, AND USES THEREOF | Fred Hutchison Cancer Center (US) | 2025-08-07 | — | — | US | claimed |
| WO-2025097015-A1 | CLEC2A-BINDING THERAPEUTICS | FRED HUTCHINSON CANCER CENTER (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025080875-A1 | CYTOMEGALOVIRUS-DERIVED CD44 BINDING PROTEINS AND USES THEREOF | LIONS EYE INSTITUTE (AU) | 2025-04-17 | — | — | WO | claimed |
| WO-2025076048-A1 | ANTI-CD90 ANTIBODIES, BINDING FRAGMENTS, AND USES THEREOF | FRED HUTCHINSON CANCER CENTER (US) | 2025-04-10 | — | — | WO | claimed |
| WO-2025036876-A2 | NEW ANTI-CANCER APPROACHES | ONA Therapeutics S.L. (ES) | 2025-02-20 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20060035945-A1 | Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases | INVESTISSEMENT QUEBEC (CA) | 2006-02-16 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-1085891-A1 | MULTIBINDING INHIBITORS OF TOPOISOMERASE | Advanced Medicine, Inc. (US) | 2001-03-28 | — | — | EP | claimed |
| WO-1999064054-A9 | MULTIBINDING INHIBITORS OF TOPOISOMERASE | ADVANCED MEDICINE INC (US) | 2000-03-02 | — | — | WO | claimed |
| WO-1999064054-A1 | MULTIBINDING INHIBITORS OF TOPOISOMERASE | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | claimed |